SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-16-004390
Filing Date
2016-01-11
Accepted
2016-01-11 18:55:29
Documents
2
Period of Report
2016-01-07

Document Format Files

Seq Description Document Type Size
1 form3-01112016_030121.html 3  
1 form3-01112016_030121.xml 3 1654
2 ex24-01112016_030122.htm EX-24 3215
  Complete submission text file 0001415889-16-004390.txt   6284
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 161337364